Clinical Trial Update: Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating safety and efficacy of PRG-1801 for lupus nephritis and IgG4-related disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Igg4-related Disease
• Lupus Nephritis

Drugs mentioned

• PRG-1801

Snippet

Sponsor: Tongji Hospital | Conditions: Lupus Nephritis, IgG4-related Disease | EARLY_Phase 1 | Status: RECRUITING